Plasma alarmin S100A8/A9 serves as a potential biomarker of major adverse cardiovascular events after acute myocardial infarction

Cardiovascular Diagnosis and Therapy · Published 2026-06-01 · DOI 10.21037/cdt-2025-1-626

Free full text

Authors (7)

Jingjiang Pi, Liang Geng, Chenghui Fan, Jing Xu, Xingxu Wang, Qi Zhang, Wei Wei

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Pi, J., Geng, L., Fan, C., et al. (2026). Plasma alarmin S100A8/A9 serves as a potential biomarker of major adverse cardiovascular events after acute myocardial infarction. Cardiovascular Diagnosis and Therapy. https://doi.org/10.21037/cdt-2025-1-626

Related articles